Related Experiment Video
Updated: May 3, 2026
Subconjunctival Administration of Adeno-associated Virus Vectors in Small Animal Models
Published on: March 16, 2022
[Application of gene therapy to oncologic ophthalmology]
A Philiponnet1, J-D Grange1, L G Baggetto2
1Clinique ophtalmologique universitaire, hôpital de la Croix-Rousse, 103, Grande-rue-de-la-Croix-Rousse, 69317 Lyon cedex 04, France.
Abstract:
Since the discovery of the structure of DNA in 1953 by Watson and Crick, our understanding of the genetic causes and the regulations involved in tumor development have hugely increased. The important amount of research developed since then has led to the development of gene therapy, which specifically targets and treats cancer cells by interacting with, and correcting their genetic material. This study is a review of the most accomplished research using gene therapy aimed at treating malignant ophthalmologic diseases, and focuses more specifically on uveal melanoma and retinoblastoma. Such approaches are remarkable regarding the efficiency and the cellular targeting specificity. However, gene therapy-based treatments are so recent that many long-term interrogations subsist. The majority of the reviewed studies are conducted in vitro or in murine models, thereby requiring several years before the resulting therapies become part of the daily ophthalmologists' arsenal. However, the recent spectacular developments based on advanced scientific knowledge justify an up-to-date review that would benefit the ophthalmologist community.
Insights
Gene therapy shows promise for treating eye cancers like uveal melanoma and retinoblastoma by targeting cancer cell genetics. While effective in early studies, further research is needed before clinical application.
Area of Science:
- Genetics
- Oncology
- Ophthalmology
Context:
- The discovery of DNA structure revolutionized understanding of tumor development.
- Gene therapy has emerged as a novel approach to target and correct genetic material in cancer cells.
- Malignant ophthalmologic diseases, including uveal melanoma and retinoblastoma, present unique challenges for treatment.
Purpose:
- To review recent advancements in gene therapy for ocular cancers.
- To evaluate the efficacy and specificity of gene therapy in treating uveal melanoma and retinoblastoma.
- To highlight the potential and limitations of current gene therapy research in ophthalmology.
Summary:
- This review examines cutting-edge gene therapy research for ocular malignancies, focusing on uveal melanoma and retinoblastoma.
- Gene therapy demonstrates high efficiency and cellular specificity in preclinical and in vitro models.
- Despite promising results, long-term outcomes and clinical translation require further investigation.
Impact:
- Provides an up-to-date overview of gene therapy applications in ophthalmology for the medical community.
- Highlights the potential of gene therapy to revolutionize the treatment of eye cancers.
- Identifies areas for future research to advance gene therapy into clinical practice for ophthalmologists.
More Related Videos
Related Concept Videos
00:59Gene Therapy
00:59Gene Therapy
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
01:20The Retinoblastoma Gene